NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1
Drug Resistance Updates · 2024
DOI: 10.1016/j.drup.2023.101040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2024. Verfasst von Zhiheng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University & Department of Hepatobiliary Surgery, Nanjing Drum To…. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui Medical University & Department of Hepatobiliary Surgery, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicin…
- Department of Hepatobiliary Surgery, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing 210008, Jiangsu, China.
- Department of Endocrinology and Metabolism, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Electronic address: yangyuhong@126.com.
Zitieren
APA
Zhang, Z., Song, B., Wei, H., Liu, Y., Zhang, W., Yang, Y., & Sun, B. (2024). NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2023.101040
Vancouver
Zhang Z, Song B, Wei H, Liu Y, Zhang W, Yang Y, et al. NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1. Drug Resistance Updates. 2024. doi:10.1016/j.drup.2023.101040
BibTeX
@article{Zhang2024,
author = {Zhang, Zhiheng and Song, Bojiao and Wei, Haowei and Liu, Yang and Zhang, Wenjie and Yang, Yuhong and Sun, Beicheng},
title = {NDRG1 overcomes resistance to immunotherapy of pancreatic ductal adenocarcinoma through inhibiting ATG9A-dependent degradation of MHC-1},
journal = {Drug Resistance Updates},
year = {2024},
doi = {10.1016/j.drup.2023.101040}
}
EUVIMED